Cargando…
Current treatment options for postmenopausal vaginal atrophy
Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%–60% of postmenopausal women who are suffering in silence from this condition. Hormonal changes, especially hypoestrogenism inherent in menopause, are characterized by a variety of symptoms. More than half of menopausal women are...
Autores principales: | Naumova, Iuliia, Castelo-Branco, Camil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074805/ https://www.ncbi.nlm.nih.gov/pubmed/30104904 http://dx.doi.org/10.2147/IJWH.S158913 |
Ejemplares similares
-
Reviewing the options for local estrogen treatment of vaginal atrophy
por: Lindahl, Sarah H
Publicado: (2014) -
A Review of Pharmacological Treatments for Vaginal Atrophy in Postmenopausal Women in Iran
por: Rashidi Fakari, Farzaneh, et al.
Publicado: (2020) -
Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy
por: Minkin, Mary Jane, et al.
Publicado: (2014) -
Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
por: Kingsberg, SA, et al.
Publicado: (2010) -
Multidisciplinary Overview of Vaginal Atrophy and Associated Genitourinary Symptoms in Postmenopausal Women
por: Goldstein, Irwin, et al.
Publicado: (2013)